Sean M. Gillen sold $1.4M of AIR
Senior VP-CFO at AAR CORP. 18,000 shares at an average of $77.37, traded Jul 23, 2025, filed Jul 25, 2025.
Score components
- +22RoleCFO
- +25Trade size$1.4M at market
- +5Share of holdings soldSold 17% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-019583, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 23, 2025 | AGrant or award Common Stock | +3,815 | $0.00 | $0 | 88,423 | Jul 25, 2025 |
| Jul 23, 2025 | AGrant or award Common Stock | +11,445 | $0.00 | $0 | 99,868 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Common Stock | +8,000 | $18.94 | $152k | 107,868 | Jul 25, 2025 |
| Jul 23, 2025 | SOpen-market sale Common Stock | -8,000 | $77.37 | $619k | 99,868 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Common Stock | +4,000 | $37.74 | $151k | 103,868 | Jul 25, 2025 |
| Jul 23, 2025 | SOpen-market sale Common Stock | -4,000 | $77.37 | $309k | 99,868 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Common Stock | +4,000 | $41.88 | $168k | 103,868 | Jul 25, 2025 |
| Jul 23, 2025 | SOpen-market sale Common Stock | -4,000 | $77.37 | $309k | 99,868 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Common Stock | +2,000 | $58.27 | $117k | 101,868 | Jul 25, 2025 |
| Jul 23, 2025 | SOpen-market sale Common Stock | -2,000 | $77.37 | $155k | 99,868 | Jul 25, 2025 |
| Jul 23, 2025 | AGrant or award Stock Optionderivative | +10,550 | $0.00 | $0 | 10,550 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Stock Optionderivative | -8,000 | $0.00 | $0 | 39,870 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Stock Optionderivative | -4,000 | $0.00 | $0 | 3,970 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Stock Optionderivative | -4,000 | $0.00 | $0 | 8,065 | Jul 25, 2025 |
| Jul 23, 2025 | MOption exercise Stock Optionderivative | -2,000 | $0.00 | $0 | 4,715 | Jul 25, 2025 |
Related signals
Other insiders at AAR CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | AAR CORP | John McClain Holmes III Chairman, President & CEO | $3.2M 38,462 shares | -13% | |
| 54Moderate | AAR CORP | John McClain Holmes III Chairman, President & CEO | $717k 10,000 shares | -3% | |
| 50Moderate | AAR CORP | Eric Pachapa VP-CAO & Controller | $365k 5,000 shares | -20% | |
| 37Weak | AAR CORP | Eric Pachapa VP-CAO & Controller | $450k 5,748 shares | -16% | |
| 29Weak | AAR CORP | Jessica A. Garascia Senior VP, GC, CAO & Secretary | $280k 3,631 shares | -9% | |
| 55Moderate | AAR CORP | John McClain Holmes III Chairman, President & CEO | $4.4M 56,551 shares | -15% | |
| 54Moderate | AAR CORP | Jennifer L Vogel director | $547k 7,000 shares | -23% | |
| 55Moderate | AAR CORP | John McClain Holmes III Chairman, President & CEO | $354k 5,000 shares | -1% | |
| 50Moderate | AAR CORP | Christopher A. Jessup Senior Vice President-CCO | $2.4M 33,981 shares | -48% | |
| 60Notable | AAR CORP | John McClain Holmes III Chairman, President & CEO | $8.6M 128,427 shares | -34% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.